Wie hoch ist der Preis für Entropy Neurodynamics Limited (ENP)

Preis für Entropy Neurodynamics Limited (ENP) ist $0.02468497

Wie hoch ist die Marktkapitalisierung für Entropy Neurodynamics Limited (ENP)

Marktkapitalisierung für Entropy Neurodynamics Limited (ENP) ist $40.28M

Entropy Neurodynamics Limited (ENP) Preis und Marktkapitalisierung

Entropy Neurodynamics Limited operates as a clinical-stage pharmaceutical company, dedicated to pioneering novel formulations for psilocin administration. These formulations are intended for use alongside psychotherapy, aiming to tackle medical conditions with pressing unmet needs across Australia, Canada, Switzerland, and the United States. The firm's flagship development is TRP-8803, an intravenously infused psilocin formulation that has successfully concluded Phase 2 clinical trials. These trials investigated its potential to treat binge eating disorder, fibromyalgia, irritable bowel syndrome, abdominal pain, and visceral tenderness. Additionally, the company is advancing TRP-8802, a synthetic, orally administered psilocybin compound. TRP-8802 is currently undergoing Phase 2a clinical trials for binge eating and is in Phase 2 clinical development for fibromyalgia and irritable bowel syndrome. Established in 2019 and headquartered in Camberwell, Australia, the company adopted its current name, Entropy Neurodynamics Limited, in November 2025, having previously operated as Tryptamine Therapeutics Limited.

Preis für ENP	Vermögenswert B	Marktkapitalisierung von B	Ergebnisse
$3,246.36 $40.28M	NVDA	$5.297T	+13,151,057.78%
$2,854.08 $40.28M	AAPL	$4.657T	+11,561,906.61%
$2,514.75 $40.28M	GOOG	$4.104T	+10,187,267.54%
$2,189.20 $40.28M	MSFT	$3.572T	+8,868,454.10%
$1,723.53 $40.28M	AMZN	$2.812T	+6,981,993.71%

Preis für ENP

Vermögenswert B

Marktkapitalisierung von B

Ergebnisse

$3,246.36 $40.28M